217 related articles for article (PubMed ID: 22825115)
1. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis and trimethoprim-sulfamethoxazole.
Forgacs P; Wengenack NL; Hall L; Zimmerman SK; Silverman ML; Roberts GD
Antimicrob Agents Chemother; 2009 Nov; 53(11):4789-93. PubMed ID: 19564358
[TBL] [Abstract][Full Text] [Related]
3. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.
Goldstein BP; Ripamonti IF; Bolzoni G; Carniti G; Arioli V
Antimicrob Agents Chemother; 1979 Dec; 16(6):736-42. PubMed ID: 533255
[TBL] [Abstract][Full Text] [Related]
4. Sulfamethoxazole enhances the antimycobacterial activity of rifampicin.
Macingwana L; Baker B; Ngwane AH; Harper C; Cotton MF; Hesseling A; Diacon AH; van Helden P; Wiid I
J Antimicrob Chemother; 2012 Dec; 67(12):2908-11. PubMed ID: 22875849
[TBL] [Abstract][Full Text] [Related]
5. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
7. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
[TBL] [Abstract][Full Text] [Related]
10. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
Stein GE; Gurwith D; Gurwith M
Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
[TBL] [Abstract][Full Text] [Related]
13. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
[TBL] [Abstract][Full Text] [Related]
14. Improbability of selection for RIF resistance in Mycobacterium tuberculosis by accidental exposure during short-course therapy with Cotrifazid.
Müller-Brundaler U; Dingfelder G; Urbanczik R
Chemotherapy; 1997; 43(6):451-2. PubMed ID: 9395860
[No Abstract] [Full Text] [Related]
15. Molecular detection of Isoniazid, Rifampin and Ethambutol resistance to M. tuberculosis and M. bovis in multidrug resistant tuberculosis (MDR-TB) patients in Pakistan.
Munir S; Mahmood N; Shahid S; Khan MI
Microb Pathog; 2017 Sep; 110():262-274. PubMed ID: 28688981
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
[TBL] [Abstract][Full Text] [Related]
18. Application of genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volume laboratory in Southern China.
Zhang L; Ye Y; Duo L; Wang T; Song X; Lu X; Ying B; Wang L
Mol Biol Rep; 2011 Mar; 38(3):2185-92. PubMed ID: 20852939
[TBL] [Abstract][Full Text] [Related]
19. Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.
Pancoast SJ; Hyams DM; Neu HC
Antimicrob Agents Chemother; 1980 Feb; 17(2):263-8. PubMed ID: 7387147
[TBL] [Abstract][Full Text] [Related]
20. Effect of drug resistance on the generation of secondary cases of tuberculosis.
Burgos M; DeRiemer K; Small PM; Hopewell PC; Daley CL
J Infect Dis; 2003 Dec; 188(12):1878-84. PubMed ID: 14673768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]